Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia
· Delayed Price · Currency is TND 7.70
-0.19 (-2.41%)
At close: May 8, 2025
BVMT:UMED Income Statement
Financials in millions TND. Fiscal year is January - December.
Millions TND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 136 | 96.36 | 84.5 | 91.04 | 107.21 | Upgrade
|
| Other Revenue | - | - | 0.01 | - | - | Upgrade
|
| Revenue | 136 | 96.36 | 84.51 | 91.04 | 107.21 | Upgrade
|
| Revenue Growth (YoY) | 41.14% | 14.02% | -7.17% | -15.07% | 23.10% | Upgrade
|
| Cost of Revenue | 61.72 | 46.8 | 38.22 | 43.69 | 48.54 | Upgrade
|
| Gross Profit | 74.29 | 49.56 | 46.29 | 47.35 | 58.67 | Upgrade
|
| Selling, General & Admin | 19.71 | 16.77 | 15.48 | 15.1 | 14.99 | Upgrade
|
| Other Operating Expenses | 9.88 | 8.27 | 6.87 | 8.37 | 7.72 | Upgrade
|
| Operating Expenses | 45.18 | 35.95 | 32.55 | 34.03 | 29.86 | Upgrade
|
| Operating Income | 29.11 | 13.61 | 13.74 | 13.33 | 28.8 | Upgrade
|
| Interest Expense | -6.22 | -3.6 | -2.63 | -3.74 | -3.93 | Upgrade
|
| Interest & Investment Income | 0.09 | 0.19 | 0.28 | 0.01 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.48 | -0.05 | -0.48 | 0.33 | -1.73 | Upgrade
|
| Other Non Operating Income (Expenses) | -11.3 | -0.22 | -0.45 | -0.69 | -1.07 | Upgrade
|
| EBT Excluding Unusual Items | 11.21 | 9.94 | 10.47 | 9.23 | 22.08 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.08 | 0.09 | 0.04 | 0.08 | 0.03 | Upgrade
|
| Asset Writedown | -0.3 | -0.2 | -0.08 | -0.04 | -0.01 | Upgrade
|
| Pretax Income | 10.99 | 9.83 | 10.43 | 9.27 | 22.09 | Upgrade
|
| Income Tax Expense | 5.45 | 2 | 1.72 | 2.29 | 4.4 | Upgrade
|
| Earnings From Continuing Operations | 5.55 | 7.83 | 8.7 | 6.98 | 17.69 | Upgrade
|
| Net Income | 5.55 | 7.83 | 8.7 | 6.98 | 17.69 | Upgrade
|
| Net Income to Common | 5.55 | 7.83 | 8.7 | 6.98 | 17.69 | Upgrade
|
| Net Income Growth | -29.17% | -10.03% | 24.69% | -60.55% | -3.64% | Upgrade
|
| Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | Upgrade
|
| EPS (Basic) | 0.17 | 0.24 | 0.27 | 0.22 | 0.55 | Upgrade
|
| EPS (Diluted) | 0.17 | 0.24 | 0.27 | 0.22 | 0.55 | Upgrade
|
| EPS Growth | -29.17% | -10.03% | 24.69% | -60.55% | -3.64% | Upgrade
|
| Free Cash Flow | 18.68 | -12.07 | 15.13 | 0.08 | -3.48 | Upgrade
|
| Free Cash Flow Per Share | 0.58 | -0.38 | 0.47 | 0.00 | -0.11 | Upgrade
|
| Dividend Per Share | - | 0.469 | 0.406 | - | - | Upgrade
|
| Dividend Growth | - | 15.52% | - | - | - | Upgrade
|
| Gross Margin | 54.62% | 51.43% | 54.77% | 52.01% | 54.72% | Upgrade
|
| Operating Margin | 21.40% | 14.12% | 16.26% | 14.64% | 26.87% | Upgrade
|
| Profit Margin | 4.08% | 8.13% | 10.30% | 7.67% | 16.50% | Upgrade
|
| Free Cash Flow Margin | 13.73% | -12.52% | 17.90% | 0.09% | -3.24% | Upgrade
|
| EBITDA | 39.11 | 23.3 | 23.02 | 22.79 | 35.8 | Upgrade
|
| EBITDA Margin | 28.75% | 24.19% | 27.24% | 25.03% | 33.39% | Upgrade
|
| D&A For EBITDA | 10 | 9.69 | 9.27 | 9.46 | 7 | Upgrade
|
| EBIT | 29.11 | 13.61 | 13.74 | 13.33 | 28.8 | Upgrade
|
| EBIT Margin | 21.40% | 14.12% | 16.26% | 14.64% | 26.87% | Upgrade
|
| Effective Tax Rate | 49.56% | 20.35% | 16.52% | 24.74% | 19.92% | Upgrade
|
| Revenue as Reported | 136.15 | 96.62 | 84.55 | 91.07 | 107.25 | Upgrade
|
Updated Jun 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.